ID   7SA
DR   Wikidata; Q54605160
RX   PubMed=1737362;
RX   PubMed=1973007;
RX   PubMed=2496488;
RX   PubMed=2505924;
CC   Transformant: ChEBI; CHEBI:2504; Aflatoxin B1 (AFB1).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0190 ! C3H/10T1/2 clone 8
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
RX   PubMed=1737362;
RA   Dunn J.A., Faletto M.B., Kasper S.J., Gurtoo H.L.;
RT   "Aflatoxin-transformed C3H/10T1/2 cells overexpress protein kinase C
RT   and have an altered response to phorbol ester treatments.";
RL   Cancer Res. 52:990-996(1992).
RX   PubMed=1973007; DOI=10.1016/0041-008X(90)90308-H;
RA   Faletto M.B., Maccubbin A.E., Ersing N., Kouli F., Vangalio J.A.,
RA   Gurtoo H.L.;
RT   "Altered benzo[a]pyrene metabolism in C3H/10T1/2 cells transformed by
RT   aflatoxin B1 or 3-methylcholanthrene.";
RL   Toxicol. Appl. Pharmacol. 104:351-366(1990).
RX   PubMed=2496488; DOI=10.1016/0041-008X(89)90230-5;
RA   Faletto M.B., Gurtoo H.L.;
RT   "The effect of inducers of mixed-function oxidases on hepatic
RT   microsome-mediated aflatoxin B1 transformation in C3H/10T1/2 cells.";
RL   Toxicol. Appl. Pharmacol. 98:252-262(1989).
RX   PubMed=2505924;
RA   Faletto M.B., Maccubbin A.E., Koser P.L., Vangalio J.A., Gurtoo H.L.;
RT   "Induction of aryl hydrocarbon hydroxylase and DNA adduct formation in
RT   parental and carcinogen transformed C3H/10T1/2 clone 8 cells by
RT   benzo[a]pyrene.";
RL   Cancer Biochem. Biophys. 10:197-205(1989).